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Understanding underlying pathological mechanisms is prerequisite for a sensible design
of protective therapies against hearing loss. The triad of age-related, noise-generated,
and drug-induced hearing loss displays intriguing similarities in some cellular responses
of cochlear sensory cells such as a potential involvement of reactive oxygen species
(ROS) and apoptotic and necrotic cell death. On the other hand, detailed studies have
revealed that molecular pathways are considerably complex and, importantly, it has
become clear that pharmacological protection successful against one form of hearing
loss will not necessarily protect against another. This review will summarize pathological
and pathophysiological features of age-related hearing impairment (ARHI) in human and
animal models and address selected aspects of the commonality (or lack thereof) of
cellular responses in ARHI to drugs and noise.
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Introduction
Acquired hearing loss is the most common hearing impairment in modern societies. Not all of its
causes, however, are of modern origin. Of themajor contributing entities, presbycusis or age-related
hearing impairment (ARHI) has been recognized by physicians and societies since ancient times.
The environmental overload with damaging noise levels, beginning with the industrial revolution,
and the introduction of ototoxic antibiotics and anti-cancer agents in the last century added to
the spectrum of hazards to the auditory system and established the current triad of drug-induced,
noise-induced and age-related hearing losses.
Medical science and research over the last centuries have given us an excellent knowledge of
inner ear pathologies and their functional consequences. Recent advances have added insights
into molecular pathways, their physiological control mechanisms, and their modulation by
environmental and genetic influences. Intriguing biochemical and molecular parallels began to
surface, leading to speculation of a common underlying mechanism of acquired hearing loss and
the prospect for a unified pharmacological protection. However, details about the individuality of
cell death and homeostatic pathways and differentiated responses to attempted protection soon
dispelled this notion. This review will focus on ARHI and compare its biochemical and molecular
characteristics to ototoxic hair cell death and noise trauma. While the overall pattern of presbycusis
is also shapedby changes in central auditorypathways,wewill limit our considerations to the cochlea.
Age-Related Hearing Impairment (ARHI)
Prevalence
ARHI is the most prevalent form of hearing loss in humans. It is characterized by
decreased hearing sensitivity, decreased ability to understand speech in a noisy environment,
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slowed central processing of acoustic stimuli, and impaired
sound localization (Gates and Mills, 2005). Based on a survey
from 2001 through 2008, Lin et al. (2011) estimated that 30
million, or 12.7% of U.S. Americans of 12 years and older had
bilateral hearing loss with elevated thresholds of >25 dB in the
better hearing ear for a speech-frequency pure-tone average at
0.5, 1, 2 and 4-kHz. The percentage of the afflicted population
increased dramatically in the elderly. Sixty-three percent of male
and 48% of female adults aged between 70 and 79 years were
affected. Similar data for Europe indicated that 30% of men and
20% of women had a hearing loss of 30 dB or more at the age
of 70 years, and 55% of men and 45% of women at the age of 80
years (Roth, 2015).
First signs of ARHI in males may already be evident at
an age of 30–39 years, beginning at the highest frequency
range of 10–16 kHz; by 40–49 years hearing impairment
has progressed to frequencies of 6–8 kHz. Presbycusis in
females generally begins a decade later, and the principal
speech band (0.5–4 kHz) is affected in both genders by 60–69
years (Sharashenidze et al., 2007). Besides gender differences,
epidemiological studies in the USA have established a higher
prevalence in Caucasians than in African-Americans (Lin et al.,
2011).
Genetics
ARHI is shaped by the interplay between genes that govern
cochlear integrity and noxious environmental events on the
inner ear. Intrinsic factors contributing to presbycusis include
genetic disorders rooted in mutations of both nuclear and
mitochondrial DNA, hypertension, diabetes mellitus, and other
metabolic and systemic diseases (Lee, 2013; Perry et al., 2014).
Noise exposure, ototoxic medications, and diet—while being able
to cause hearing loss independently—are modulating extrinsic
factors of ARHI. The overall impact of individual genetic factors
in the development of ARHI in humans remains uncertain
but there is evidence for their major contribution in familial
aggregation of presbycusis (Raynor et al., 2009). Siblings of
individuals with hearing loss had more than four times higher
odds of also having hearing loss than siblings of individuals
without hearing loss; the risk ratio was greater in women
than men. Overall, about half of the variance in this cluster
of ARHI could be ascribed to genetic factors the precise
nature of which remains elusive. ARHI seems to be polygenic
but no major common genetic variants have been identified
(Fransen et al., 2015). In agreement with human findings,
recent animal studies suggest multiple genetic influences on
the progression of ARHI and on the interaction of age with
noise in mice (Noben-Trauth and Johnson, 2009; Ohmen et al.,
2014). Results from the offspring of 4-way-cross mice provided
evidence for several specific alleles that affected hearing at select
frequencies, ages, or following noise trauma (Schacht et al.,
2012a).
An intriguing question is a potential relationship between
presbycusis and late-onset hearing loss due to highly penetrant
monogenic mutations. The age of onset of both is fluid but a late-
onset hearing loss is generally evident by young adulthood. Any
genetic similarities or differences are yet to be determined.
Impact of Lifestyle and Disease
Lifestyle may influence auditory performance at any age as
well as the progression of presbycusis. In a cross-sectional
analysis of 164,770 participants, smoking and passive smoking
was associated with increased odds of hearing loss in a dose-
dependent manner (Dawes et al., 2014). In contrast, moderate
use of alcohol was associated with better hearing in the elderly
in three independent studies (Popelka et al., 2000; Fransen et al.,
2008; Gopinath et al., 2010a), an effect in line with observations
that low alcohol intake can be beneficial for general health.
Heavy drinkers, in contrast, as well as those with a high body
mass index, had a tendency toward more pronounced high-
frequency hearing loss. Such differential influences of lifestyle
might be related to overall health, especially in association with
cardiovascular disease. A cause of microvascular abnormalities
that also might affect hearing is type 2 diabetes mellitus (Mitchell
et al., 2009). Type 2 diabetes, often associated with overweight
and obese body habitus in adults as well as in youth, is a
common metabolic disease that causes impairment of various
organ systems. Data from a large longitudinal cohort study
indicate that type 2 diabetes is associated with prevalent hearing
loss and a significant accelerated progression of hearing loss in
patients with newly diagnosed diabetes (Mitchell et al., 2009).
Since diet is one of the few potentially modifiable risk factors
for age-related hearing loss, the impact of nutritional behavior
has frequently been investigated (Gopinath et al., 2010a, 2011b).
Both a high-carbohydrate diet and a high dietary intake of
cholesterol were associated with ARHI. In contrast, treatment
with 3-hydroxy-3-methyl-glutaryl (HMG) CoA reductase drugs
(statins) and consumption of monounsaturated fats and cereal
fibers inclined toward a lower prevalence of hearing loss. We will
discuss more aspects of dietary manipulations of ARHI in the
‘‘Antioxidants and Vitamins in Human Hearing and Prevention
of Hearing Loss’’ Section.
Cochlear Pathology in Humans and Animal
Models
A hallmark of human ARHI is the variability of its pathology.
Although high-frequency hearing loss appears to be a prevalent
form, some individuals may also show a gradually sloping or
a flat audiometric curve (Suga and Lindsay, 1976). Moreover,
different structural elements can be affected such as hair cells,
neurons, lateral wall tissues, or a combination thereof (Nelson
and Hinojosa, 2006). This variability has been ascribed to
genetic susceptibility modified by environmental effects of noise
exposure, disease, and lifestyle. In practice, ARHI is largely an
umbrella term for multiple forms of auditory pathology manifest
in aging individuals.
In contrast, drug- and noise-induced hearing loss tend
to present a well-defined pattern of damage in both human
and experimental animals. Both aminoglycoside antibiotics and
cisplatin primarily damage outer hair cells in a predictable base-
to-apex progression. Noise trauma may initially affect fibrocytes
of the spiral ligament (Hirose and Liberman, 2003) and will—at
higher intensities or longer duration—damage hair cells in
relation to the frequency and intensity of the stimulus.
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Sensorineural Elements
Sensory hair cell loss has been documented in temporal bones
of patients with ARHI but does not appear to be its only
determining cause. The area of destruction was usually located
in the basal end of the cochlea causing a threshold elevation
at 8 kHz but rarely extended towards the apex far enough to
involve speech frequencies (Schuknecht and Gacek, 1993). More
recent studies of temporal bones have expanded this view by
showing significant degeneration of multiple cochlear elements
including stria vascularis and spiral ganglion cells that better
correlate with the severity of hearing loss (Nelson and Hinojosa,
2006). Specifically, the extent of ganglion cell degeneration was
associated with the slope of the descending high-frequency
component of the audiogram. In addition, several reports have
indicated nerve damage in the presence of apparently intact
hair cells in ARHI (Sone et al., 1998; van Ruijven et al., 2005;
Linthicum and Fayad, 2009).
Animal models that reflect a sensorineural ARHI with loss
of outer and, later, inner hair cells include aging rats and
mice. CBA/J mice as well as the CBA/CaJ and CAST strains
present little evidence of hearing loss until 18 months of age,
i.e., long into their lifespan, when they begin to show hair cell
loss and elevated auditory thresholds (Li and Borg, 1991; Sha
et al., 2008). In contrast, the C57BL/6, BALB and DBA/J strains
develop a severe high-frequency sensorineural hearing loss as
early as 5 weeks in DBA or 3 months of age in C57BL/6 (Zheng
et al., 1999). Those strains carry a mutation of the cadherin 23
(Cdh23) gene at the ahl locus predisposing them to accelerated
hearing loss, distinct from the late-life age-related changes in
other mouse strains and in human. Indeed, no convincing
evidence yet exists associating variants in human CDH23 with
ARHI. For example, a recent study of 310 aging participants
with poor hearing vs. 308 participants with good hearing found
no association of a common CDH23 variant with presbycusis
(Hwang et al., 2012b). These facts should therefore disqualify
strains carrying the Cdh23ahl allele as models of typical ARHI
in human. Likewise, mouse models with defective mitochondrial
DNA repair mechanisms may show an accelerated hearing loss
that does not reflect human presbycusis (see ‘‘Involvement of
Mitochondria’’ Section).
Degeneration of spiral ganglion cells can also be observed in
animal models of aging. The degeneration may follow the loss
of hair cells but may also occur independently (Keithley et al.,
1989; Sha et al., 2008). Conversely, spiral ganglion cells may be
preserved in the presence of a degenerated cochlea (White et al.,
2000). More recently there has been evidence for synaptopathy as
a pathophysiological process underlying supra-threshold deficits.
In mice, degeneration of cochlear synapses in age-related hearing
loss preceded both cochlear nerve degeneration and hair cell loss
and occurred long before a threshold elevation was measurable
(Kujawa and Liberman, 2015). In fact, these observations
may relate to a report by Crowe et al. (1993) on ‘‘dendritic
presbycusis’’ in which human temporal bones presented a normal
cochlea but a loss of dendritic processes of the spiral ganglion
(Rizk and Linthicum, 2012).
Synaptopathy may also be a consequence of noise exposure or
aminoglycoside treatment. Following a noise exposure regimen
that initially only led to a temporary threshold shift as assessed by
auditory brainstem response (ABR), compound action potential
and distortion-product otoacoustic emission (DPOAE; Kujawa
and Liberman, 2009), the synapses from the afferent nerve fibers
to the inner hair cells were the most vulnerable elements at
a later age, not the hair cells, resulting in an attenuation of
supra-threshold neural responses. Threshold elevations without
a reduction in hair cell counts have also been observed after
kanamycin administration in guinea pigs (Nicol et al., 1992).
In a mouse model of enhanced endoplasmic reticulum stress
(Oishi et al., 2015) gentamicin caused synaptopathy; spiral
ganglion cells and inner hair cell synapses were reduced
while hair cells remained intact by morphology and DPOAE
measurements.
The complexity of age-related changes clearly calls for
carefully selected animal models and detailed assessments of
auditory pathophysiology. Appropriate animal models would
develop hearing loss with advanced age and not be confounded
by mutations that disrupt the physiological aging process. In
addition to loss of hair cells, neuronal elements including
synaptic connections need to be evaluated. As a physiological
measure, ABR thresholds are insufficient just as a pure-tone
audiogram would be insensitive to diffuse neural degeneration
and an impaired understanding of complex sounds in humans.
Therefore animal experimentation needs to consider supra-
threshold deficits and performance in simple behavioral tasks
such as gap detection (Altschuler et al., 2015).
Stria Vascularis and Spiral Ligament
As briefly mentioned in the preceding section, age also changes
the morphology of cochlear supporting tissues. For example, the
volume of stria vascularis and spiral ligament was significantly
lower in temporal bones of older (64–84 years old) than in
younger (15–38 years old) subjects (Ishiyama et al., 2007).
More to the point, strial atrophy was a frequent occurrence in
temporal bones of individuals that had been diagnosed with
ARHI (Schuknecht et al., 1974; Suga and Lindsay, 1976; Nelson
and Hinojosa, 2006). However, there is no indication that strial
pathology can be a sole cause of hearing loss. In fact, the best
correlation between the severity of ARHI and morphological
changes was established for the extent of degeneration of all
four cochlear elements, namely stria vascularis, spiral ganglion
cell, inner and outer hair cells (Nelson and Hinojosa, 2006).
The observation that ABR thresholds were not associated with
a single peripheral deficit was also made from a study of age-
related hearing loss in rhesus monkeys (Engle et al., 2013). Spiral
ganglion density and loss of outer hair cells contributed to the
audiometric impairments but neither did decreases in inner
hair cell numbers or thickness of stria vascularis. The strongest
correlation was seen with the number of different pathologies
present.
Human studies cannot evaluate the metabolic consequences
of strial pathology on the endocochlear potential. Animal models
indicate strial dysfunction is not a prerequisite for loss of hair
cells. Although CBA/CaJ mice may display a gradual decline
in endocochlear potential during aging, other strains such as
CBA/J maintain a stable potential (Sha et al., 2008; Ohlemiller
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et al., 2010) while developing ARHI. Conversely, however, a
significant decline in endocochlear potential should lead to
impaired auditory processing. Among animals, the Mongolian
gerbil is considered a model for a strial contribution to hearing
loss with age. Strial atrophy was variable but Na, K-ATPase
activity and the endocochlear potential tended to decrease
(Schulte and Schmiedt, 1992).
Morphological changes in the stria may also be associated
with treatment by drugs and noise but may not be causal
to hearing loss. Strial pathology can be observed after
aminoglycoside challenge (Forge et al., 1987), but the
endocochlear potential remains stable until late in ototoxic
treatment (Komune et al., 1987; Xiong et al., 2011), negating a
functional consequence of such alterations. Cisplatin may affect
both strial morphology and function (Laurell et al., 2007) but
at least some of these changes are reversible (Klis et al., 2000)
and therefore not a direct cause of hair cell loss. The effects of
noise on lateral wall tissues are variable, probably determined
by the intensity of the treatment or species differences, but
noise trauma caused degeneration of fibrocytes and edema with
temporary changes to the endocochlear potential (Hirose and
Liberman, 2003). Considering the sum of the evidence it appears
that strial pathology, although seen to some extent in the aging
and drug- or noise-treated cochlea, is not a primary or decisive
cause of acquired hearing loss.
Molecular Pathology
Oxidative Stress
Potentially detrimental reactive oxygen species (ROS) are
produced in every cell by enzymatic reactions and mitochondrial
respiratory mechanisms. However, only their excess—either
via overproduction or insufficient detoxification—will
create oxidative stress and potentially trigger cell death.
A well-maintained redox balance is important for the cochlea
as for any other tissue. Transgenic mice with deficiencies in
antioxidant systems, lacking the enzyme copper/zinc superoxide
dismutase, lost hair cells and auditory neurons to a greater
extent than their normal littermates (McFadden et al., 1999;
Keithley et al., 2005). Outer hair cells, especially those in the
base of cochlea, appear to be highly sensitive to ROS damage as
compared to supporting cells (Sha et al., 2001).
Human studies have only been able to approach a potential
link between oxidative stress and hearing performance indirectly
via the determination of stress markers in serum. A group
of 63 subjects with diabetes mellitus and diabetic hearing
impairment showed significant increases in serum levels of
oxidation markers and enzymes such as glutathione peroxidase
and superoxide dismutase (Aladag et al., 2009). Serum levels
of several ROS species were also determined in a cross-
sectional study on 302 subjects aged 40–77 years with or
without clinically diagnosed age-related sensorineural hearing
loss (Hwang et al., 2012a). Assays reflecting the combined
concentrations of hydrogen peroxide, hypochloride and hydroxyl
radicals showed a significant positive association between their
elevated levels and pure-tone thresholds at low (250–1,000 Hz)
and high frequencies (2,000–8,000 Hz). An indicator for
superoxide, in contrast, only implied an association with low-
frequency thresholds.While such associations are intriguing they
cannot provide information on potential causal relationships
or the redox status of the auditory system. Interestingly,
the use of antioxidant supplementation (vitamins C and E,
folate, coffee, and tea), which was reported by 66% of the
participants in the latter study, had no influence on auditory
performance.
Animal studies, unfortunately, do not resolve the question
of how oxidative stress relates to the development of ARHI. In
a CBA mouse model of age-related hearing loss (Jiang et al.,
2007) markers of oxidation began to appear at 12–18 months
of age in the organ of Corti and later (at 23 months) in spiral
ganglion cells, stria vascularis and spiral ligament. Conversely,
components of cellular antioxidant systems had decreased by
18 months in the organ of Corti. This evidence of an imbalanced
redox system resembles the pattern of oxidative stress in animal
models of drug-induced hearing loss and noise trauma. A striking
contrast, however, is the fact that a case can be made for a
causal relationship in the latter two pathologies but not in
ARHI: dietary manipulations reducing oxidative stress effectively
protect against aminoglycoside ototoxicity and the permanent
effects of noise trauma but not against AHRI (Oishi and Schacht,
2011; Xie et al., 2011).
The complexity of mechanisms underlying age-related
cochlear pathology and pathophysiology were further
illustrated by studies employing caloric restriction in mice.
Caloric restriction is a well-established regimen to increase
stress-resistance by curbing ROS (Sohal and Weindruch,
1996). Such a diet can extend longevity, slow age-related
physiological declines, and decrease tumor and disease
burden in a variety of animal species. Willott et al. (1995)
evaluated ARHI in 15 different mouse strains maintained
on a well-controlled calorically restricted diet beginning at
a young age. The results varied profoundly between strains.
They ranged from an amelioration of age-related hearing loss
(as measured by auditory brainstem response or cochlear
pathology) to no apparent effect and to an acceleration and
exacerbation of hearing loss. Hence, genetic heterogeneity
had a greater influence on auditory performance than
caloric restriction. By extension, genetics can be expected
also to influence the outcome of dietary manipulations with
antioxidants.
From the sum of these results, we can postulate that oxidative
stress can accompany but is not an obligatory condition for
ARHI. The ‘‘Antioxidant Protection in Animal Models’’ Section
will further explore this notion.
Involvement of Mitochondria
A decisive role of mitochondria in the aging process in
general seems firmly established. Mitochondria are particularly
vulnerable to the cumulative effects of genetic or environmental
damage because mitochondria, in contrast to nuclei, lack an
efficient DNA-repair system and protective histones. Hence,
mutations in the mitochondrial DNA (mtDNA) for the 13
proteins that it encodes are more likely to occur and persist in
a lifetime than mutations in nuclear DNA. As a consequence,
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mitochondrial function may be compromised and pathology
can become evident, varying with cell type and the type of
mutation (Lee and Wei, 2012). While much emphasis has
been placed on the formation of ROS by mitochondria, recent
evidence expands the spectrum of mitochondrial dysfunction
to their turnover (fusion and fission) and energetics, regulation
of calcium dynamics and apoptosis (Gonzalez-Freire et al.,
2015).
An involvement of mitochondria in ARHI is supported
by several lines of evidence. Patterns of maternal inheritance
of presbycusis are one indication (Hutchin and Cortopassi,
2000). Likewise, a considerable literature confirmsmitochondrial
mutations in the temporal bones of patients with presbycusis
(Fischel-Ghodsian et al., 1997). Such mtDNA mutations are
highly variable, targeting different segments of the DNA, and
often involving large-scale deletions in genes necessary for
energy metabolism (Chen and Tang, 2014). Specifically, a
mtDNA4977 deletion was more prevalent in temporal bones
from patients with presbycusis than in individuals with normal
audiograms (Bai et al., 1997) or in age-matched controls
and young and middle-aged groups (Dai et al., 2004). A
comparison of individual audiometric thresholds with levels
of the mtDNA4977 deletion in archival human cochlear
tissue (quantified by polymerase chain reaction) was able
to establish a significant correlation between the severity of
presbycusis and the deletion (Markaryan et al., 2009). While
this evidence is solid, another study indicated that mitochondrial
mutations per se do not determine the rate of age-related
deterioration of hearing. An analysis of the mitochondrial
genome of 200 individuals with normal hearing and 200
with significantly elevated thresholds (Bonneux et al., 2011)
found a lack of an association between the mutation load of
inherited mitochondrial variants and ARHI. A combination
of mitochondrial defects with other environmental or genetic
influences on the inner ear has to be postulated in these
cases.
As animal models reflecting mitochondrial pathology, mouse
mutants deficient in mitochondrial proofreading have been
suggested (Kujoth et al., 2005). However, these animals are
afflicted with dramatic degenerative changes in phenotype with
devastating effects on the animals’ health that are not shared
by late-life wild-type mice. Such ‘‘catastrophic mutations’’ do
not represent a normal aging process (Gershon, 2005; Miller,
2005) and we have to treat results from these mouse strains
with caution. Another example of a confounding mitochondrial
mutation is the DBA/2mouse which, in addition to harboring the
Cdh23ahl allel, presents defects in the respiratory chain (Someya
et al., 2007; Johnson et al., 2008). It is yet to be established
whether information derived from these models contributes to
or distracts from our understanding of ARHI.
Among the other forms of acquired hearing loss, a direct effect
on mitochondria can be deduced for aminoglycoside ototoxicity:
the decoding site of mitochondrial RNA is structurally highly
similar to the corresponding decoding site in bacteria, where
aminoglycosides bind and inhibit protein synthesis. Drug
affinity to mitochondrial RNA has indeed been correlated
with ototoxicity (Shulman et al., 2014) and non-ototoxic
aminoglycosides have been developed on the basis of differential
binding to bacterial and mitochondrial RNA (Duscha et al.,
2014). As a consequence (or independently) the drugs may
disrupt the respiratory complexes (Jensen-Smith et al., 2012)
compromising energy metabolism or initiating cell death
pathways.
The mechanism by which mitochondria might participate
in acute noise damage may have several components. A
reduction in cochlear blood flow and oxygen availability would
lead to inefficient oxidative phosphorylation and a rapid
depletion of ATP levels (Chen et al., 2012). This impairment
of mitochondrial function may be coupled with a ‘‘reperfusion
effect’’ when blood flow resumes, causing excess ROS formation.
An elevation of intracellular free calcium following noise
exposure (Fridberger et al., 1998) is another potential trigger
of mitochondrial dysfunction. Although calcium does not
directly affect the respiratory chain, it may affect mitochondrial
membrane permeability in addition to activating cell-damaging
lipid peroxidation or protein kinase pathways.
In summary, there is clear evidence that mitochondria play
a role in all three forms of acquired hearing loss (Böttger
and Schacht, 2013). However, the detailed mechanisms diverge
between these pathologies, perhaps even with only little overlap.
Primary disruptions appear to be mtDNA deletions (in ARHI),
dysfunction of mtRNA processes (aminoglycosides), and a
compromised respiratory metabolism (noise trauma), providing
examples of the multifaceted contributions of a single organelle.
Cell Death Pathways in Animal Models
Following a lethal insult, cells will undergo a controlled demise.
The classical forms of cell death, apoptosis and necrosis, and
related pathways have been documented for ARHI in animal
models where they may operate in parallel or sequentially.
Apoptosis was evident in aging rat cochleae and in outer hair
cells of both middle-aged (12-month-old) and old (18–26-
month-old) CBA/J mice with hearing deficits. The middle-
aged mice also bore nuclei with necrotic features, which
were absent from old mice (Hu et al., 2008; Sha et al.,
2009).
Essential effectors of intrinsic apoptosis are the caspases,
proteases that are sometimes termed ‘‘executioner’’ proteins.
Their activities are modulated by the Bcl-2 family of apoptosis
regulators. Bax and Bak, pro-apoptotic proteins in the Bcl-2
family, translocate to mitochondria and lead to an increase of
mitochondrial membrane permeability resulting in the release
of cytochrome c; activated caspase-9 and caspase-3 then initiate
signaling pathways towards cell death. These caspase-dependent
pathways and the participation of Bcl family of proteins have
been established for age-related hearing loss in vivo in the gerbil,
the rat, and the mouse (Alam et al., 2001; Hu et al., 2008;
Sha et al., 2009). Commensurate with apoptotic events is the
translocation of endonuclease G in animal models of ARHI
(Sha et al., 2009). Apoptosis-inducing factor and endonuclease
G translocate from mitochondria to the nucleus, promoting
chromatin condensation and DNA fragmentation.
Another route to cell death associated with ARHI is
the MAPK pathway. Mitogen-activated protein kinases
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(MAPKs) are a family of kinases that include c-jun NH2-
terminal kinases (JNK), p38 MAPKs, and other extracellular
signal-regulated kinases. Immunohistochemical analyses in
the cochlea of aging CBA/J mice demonstrated increased
phosphorylation (i.e., activation) of JNK and p38 MAPK
in outer hair cells (Sha et al., 2009). A screen for gene
expression patterns in the aging CBA mouse cochlea (Tadros
et al., 2008) likewise found significant changes with age
that included the family of caspases, MAP kinases, and
calpains.
Calpains and cathepsins are calcium-dependent proteases
that activate downstream pathways by proteolysis of target
proteins. They are components of caspase-independent
signaling to cell death, released from lysosomes in response
to increased intracellular calcium, and implicated in apoptotic
and necrotic cell death. Both of these proteases are activated
in the aging mouse cochlea (Sha et al., 2009). In addition,
the same study also demonstrated cytochrome c release,
activation of caspase-9, translocation of endonuclease G
and the involvement of the MAPK pathway, indicating
that multiple cell death pathways can be proceeding
concurrently.
There is considerable overlap in cell death pathways
between the three pathologies. Apoptotic markers have been
demonstrated for aminoglycoside ototoxicity in guinea pig
cochlear and vestibular sensory epithelia (Lang and Liu, 1997;
Nakagawa et al., 1998), for cisplatin ototoxicity in the gerbil
(Alam et al., 2000), and for noise-induced hearing loss in the
guinea pig and chinchilla (Yang et al., 2004). Necrotic hair cells
appeared in response to aminoglycosides in CBA/J mice (Jiang
et al., 2006a) and following noise exposure in the chinchilla, but
have rarely been observed as a result of cisplatin ototoxicity.
Active caspase-3 and caspase-9 or cytochrome c release may
accompany hair cell death in response to aminoglycosides in
various model systems (Cunningham et al., 2002; Wei et al.,
2005), to cisplatin in vivo (Devarajan et al., 2002), and following
noise exposure (Nicotera et al., 2003). Upstream of caspases,
Bcl-2 family proteins were induced by aminoglycosides in the
zebra fish lateral line (Coffin et al., 2013), by cisplatin in the
gerbil, and by noise in the CBA/J mouse and the guinea pig
(Vicente-Torres and Schacht, 2006; Yamashita et al., 2008).
Translocation of endonuclease G is also evident in animal
models of aminoglycoside ototoxicity (Jiang et al., 2006a) and
noise-induced hearing loss (Yamashita et al., 2004). Further
extending the similarities, p38 MAPK and JNK are involved
in aminoglycoside ototoxicity (Pirvola et al., 2000; Wei et al.,
2005) and noise trauma (Wang et al., 2003; Jamesdaniel et al.,
2011). Finally, both calpain and cathepsin were activated in
response to aminoglycoside treatment in vivo (Jiang et al.,
2006a) and calpain in response to noise exposure (Wang et al.,
1999).
This commonality of cellular responses reflects the fact that
even widely different initial insults to cell integrity will converge
into a few final pathways of cell death. Intimately linked to
the emergence of such pathways is the recruitment of survival
mechanisms. The balance between these competing forces will
ultimately decide cell fate.
Protection from Cochlear Pathology and
Pathophysiology
Homeostatic (Cell Rescue) Pathways in Animal
Models
A first response of cells under attack by potentially injurious
stimuli will be to maintain their integrity by evoking
homeostatic pathways. In the case of acquired hearing
loss, upregulation of antioxidant defenses appears to be a
ubiquitous response. In fact, in a direct comparison, Chen
et al. (2013) demonstrated the upregulation of the antioxidant
peroxiredoxin 3 in mice in vivo after acute noise exposure,
after a 2 week treatment with kanamycin, and in the cochlea
of 19-month-old animals. Likewise, heat shock proteins which
stabilize protein structure against cell stress will attenuate
loss of hair cells or auditory function by drugs (Taleb et al.,
2009), noise (Yoshida et al., 1999), and age (Mikuriya et al.,
2008). Another canonical protective pathway mediated by
phosphatidylinositol 3,4,5-trisphosphate/Akt signaling has
been documented for aminoglycoside ototoxicity (Chung
et al., 2006; Jiang et al., 2006b) and ARHI (Sha et al., 2010).
Both the knowledge of cell death and molecular rescue
pathways can provide a rational basis for the choice of
pharmacological agents to prevent or attenuate acquired
hearing loss.
Antioxidant Protection in Animal Models
There was early tantalizing support for antioxidant protection
against ARHI. A prospective randomized study had suggested
that dietary supplementation might delay or mitigate auditory
damage. Treated Fischer 344 rats had improved auditory
sensitivities in old age but the improvements were small and
differed with different antioxidants while the number of long-
term surviving animals was low (Seidman, 2000). Later studies
using a variety of different approaches yielded ambiguous
results or were met with failure, shedding doubt on the general
applicability of such an intervention.
The deterioration of auditory neurons and stria vascularis was
reduced in beagle dogs that were fed an antioxidant-enriched
diet (supplemented with vitamin E, l-carnitine, lipoic acid, and
vitamin C) for the last 3 years of their lives (Le and Keithley,
2007). Unfortunately, the study was confounded by excessive
noise in the dog kennel and it could not be ruled out that some
of the pathology attenuated by the diet had been noise-induced.
The same authors investigated transgenic mice overexpressing
mitochondrial superoxide dismutase (SOD2) as a means to
reduce oxidative stress. Contrary to expectation, hearing loss at
20 months of age was greater in transgenics than in the parent
strain of B6 mice. This result complemented an earlier study
(Keithley et al., 2005) in which the overexpression of cytosolic
copper-zinc superoxide dismutase (SOD1) also did not prevent
age-related hearing loss.
Outright failures of dietary intervention were observed in an
attempt to lower oxidative stress by strengthening mitochondrial
energy metabolism with acetyl L-carnitine in 15- to 24-months
old rats (Bielefeld et al., 2008). Auditory performance was
not affected although it could be argued that the duration of
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intervention of up to 90 days might have been insufficient.
Sha et al. (2012) subjected CBA/J mice to a long-term dietary
treatment from 10 to 22 months of age, spanning a period from
normal auditory thresholds to significant hearing loss. Food
enriched with a combination of vitamins A, C, E and α-lipoic acid
did not delay or attenuate age-related hearing loss.
In striking contrast to ARHI, reliably positive results have
been achieved with antioxidants in preventing hearing loss
caused by drugs or noise. Recent review articles have extensively
discussed mechanisms and therapeutic approaches to reduce the
ototoxic impact of cisplatin and aminoglycosides (Huth et al.,
2011; Xie et al., 2011; Schacht et al., 2012b) as well as noise
trauma (Oishi and Schacht, 2011). This contrast in efficacious
protection reinforces the conclusion put forth in the ‘‘Oxidative
Stress’’ Section that oxidative stress can accompany ARHI but
cannot its sole cause.
Antioxidants and Vitamins in Human Hearing and
Prevention of Hearing Loss
Lifestyle and diet influence both our general health and our
sense of hearing (see ‘‘Impact of Lifestyle and Disease’’ Section).
To what extend these two effects can be distinguished is an
interesting theoretical question but of no practical consequence.
Diet is an easily modifiable factor and any delay in ARHI would
have important implications for public health. Unfortunately,
there is no simple remedy.
Influence of Vitamins on the Prevalence of Hearing
Loss
An adequate intake of vitamins is essential for normal
auditory function as a number of cross-sectional studies have
demonstrated. Spankovich et al. (2011) compared pure-tone
audiometry and otoacoustic emissions with dietary data for
2,111 adults, aged 49–99 years of age. Better hearing was
associated with higher reported intake of vitamin C, vitamin E,
riboflavin (vitamin B2), magnesium, and lycopene (a carotenoid
antioxidant). Similarly, an epidemiological study of 1,910
Korean subjects aged 50–80 years compared their hearing
thresholds with self-reported intake of dietary supplements
(Kang et al., 2014). The intake of vitamin C, and to
a lesser extent retinol (a vitamin A analog), riboflavin
(vitamin B2), and niacin (vitamin B3) positively correlated
with better thresholds. A survey of a general population
in the USA aged 20–69 years (2,592 subjects) likewise
found that diets high in vitamin C, beta-carotene, and
magnesium were correlated with better hearing (Choi et al.,
2014).
However, results from surveys of different populations do not
always agree. For example, auditory thresholds were impaired in
subjects (55 women aged 60–71 years) with low serum levels of
folic acid (vitamin B9) and vitamin B12 (Houston et al., 1999).
Another cross-sectional study of presbycusic subjects confirmed
that low serum folate levels (<11 nmol/L) increased the odds of
prevalent mild hearing loss (Gopinath et al., 2010b). In contrast,
Berner et al. (2000) failed to demonstrate any association between
hearing level and vitamin B12 or folic acid in 91 elderly subjects.
A poor vitamin B12 status was also evident in 93 older adults
with hearing loss (Park et al., 2006) but short-term dietary
supplementation with vitamin B12 did not affect their hearing.
Another caveat is that an overuse of vitamins may be
detrimental to the auditory system. Higher vitamin A intake
(Spankovich et al., 2011) and higher serum levels of vitamin D
(Kang et al., 2014) have been associated with worse hearing.
Influence of Vitamins on the Incidence of Hearing
Loss
Even if a balanced or fortified diet generally promotes good
health and hearing, a direct impact of nutritional supplements
on the progression of ARHI remains debatable. A good
example of a discord between the influence of nutrition on
prevalence and on incidence of hearing loss comes from
cross-sectional and longitudinal analyses of 2,956 participants
of age 50 and older (Gopinath et al., 2011a). A segment
of the study group that took dietary vitamin E or vitamin
A had a 14% and a 47% reduced risk, respectively, of
prevalence of a moderate (or greater) hearing loss. Over
a 5-year follow-up period, however, an increased dietary
intake had no influence on the incidence of ARHI during
that time.
A prospective cohort study of 26,273 men aged 40–74 years
reported a similar lack of benefits (Shargorodsky et al., 2010). The
group was followed for 18 years and 3,559 cases of hearing loss
were documented. There was no significant association between
the risk of hearing loss and the self-reported intake of Vitamin
B12, vitamin C, vitamin E, or beta carotene.
The utility of antioxidant treatments was further cast in doubt
in a recent prospective, placebo-controlled, double-blind and
randomized trial with 120 participants of 60 years of age or
older (Polanski and Cruz, 2013). The subjects were treated for
6 months with one of four regimens: α-lipoic acid plus vitamin
C, papaverine chlorhydrate plus vitamin E, gingko extract, or
placebo. The various supplements had no effect on pure tone
audiometry, speech recognition threshold, or percentage index
of speech recognition, regardless whether measured between
groups or longitudinally over time.
A possible exception to this scenario of failures is folic acid.
A double-blind randomized and placebo-controlled study in 728
older men and women (Durga et al., 2007) provided evidence
for the efficacy of folic acid supplementation. Over a 3-year
period, the decline in low-frequency hearing was significantly
attenuated in elderly participants compared with a placebo
group. However, the effect was modest (0.7 dB) and high-
frequency hearing was not rescued. A caveat applies: the study
was conducted in the Netherlands where food products are
not fortified with folic acid. In many industrialized countries,
folic acid is added to flour in order to prevented neural tube
defects in infants. However, confirmative data were obtained
in the prospective cohort study cited above (Shargorodsky
et al., 2010). Folate reduced the risk of hearing loss in men
older than 60 years when comparing the highest quintile vs.
lowest quintile of intake. The authors offer the explanation
that high folic acid intake is necessary to overcome an age-
related increased prevalence of folate malabsorption and folate
depletion.
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Antioxidants as Protection Against Drugs and Noise
The reliable protection achieved with antioxidants against drugs
and noise trauma in animal models has prompted several trials
in humans. Based on the efficacy of salicylate in a guinea pig
model of ototoxicity (Sha and Schacht, 1999), aspirin (acetyl
salicylate) was co-administered with gentamicin in a randomized
double-blind clinical trial involving 195 patients (Sha et al., 2006).
Fourteen of 106 subjects in the control group but only 3 of 89
in the aspirin group met the criteria of hearing loss (≥15 dB
threshold shift at both 6 and 8 kHz unilaterally or bilaterally),
representing a 75% reduction of the incidence of hearing loss.
This study provided the first proof-of-principle that it is possible
to translate animal experiments in the field of acquired hearing
loss to the clinic. An independent follow-up trial with 30
patients per group confirmed the efficacy of aspirin (Behnoud
et al., 2009). Another antioxidant, N-acetylcysteine (NAC) also
attenuated ototoxicity caused by aminoglycosides in patients
with bacteremia receiving hemodialysis (Feldman et al., 2007).
Of 20 patients in the control group, 11 showed elevated pure-
tone hearing thresholds at the follow-up examination as opposed
to only 2 of 20 patients in the NAC group. In contrast, a small-
scale study of vitamin E in the prevention of aminoglycoside
ototoxicity was not successful (Kharkheli et al., 2007).
Therapeutic agents to mitigate noise-induced hearing loss in
human subjects have included magnesium which is primarily a
vasodilator, not an antioxidant (Attias et al., 1994), and NAC. In
an attempt to reduce temporary threshold shifts after exposure
to loud music in 31 normal subjects, NAC was not effective
in protecting pure-tone thresholds and distortion product
otoacoustic emissions (Kramer et al., 2006). Likewise, Lindblad
et al. (2011) found no significant differences in temporary noise-
induced threshold shifts and DPOAE amplitude in military
personnel after a shooting exercise. However, more sensitive
supra-threshold measurements (psycho-acoustical modulation
TABLE 1 | Selected features of acquired hearing loss.
Age Drugs Noise
Pathology
Organ of Corti Loss of hair cells in sensorineural
hearing loss
Loss of (primarily outer) hair cells Dislocation of tectorial membrane from
stereocilia; breaking of tip links; loss of
hair cells
Stria vascularis (and spiral ligament) Compromised structure and possibly
function in some forms of hearing loss
Aminoglycosides: endolymphatic
potential (EP) unaffected
Cisplatin: EP may be decreased
May reduce EP; loss of fibrocytes
Spiral ganglion and auditory nerve Reduced in sensorineural hearing loss;
loss of synaptic connections
Loss considered mostly secondary; loss
of synaptic connections possible
Loss of synaptic connections
Reactive oxidant species
Evidence Causal relation largely not supported + +




mitochondria; NADPH oxidase; calcium
influx may cause oxidative stress
Effects on mitochondria
mtDNA mutations might impair auditory
function; specific mutations correlate
with presbycusis in human
Aminoglycosides: Bind to mtRNA and
impair mitochondrial protein synthesis
and function; inhibition of the electron
transport chain
Reduced blood flow may impair
oxidative phosphorylation
Potential cell death pathways
Apoptosis + + +
Necrosis + Aminoglycosides: +
Cisplatin: ?
+
MAPK pathway + Aminoglycosides: +
Cisplatin: JNK ?
+
Caspase-dependent ? Evidence mostly from in vitro studies +
Caspase-independent ? In vivo + +
Potential cell rescue pathways
Homeostasis (e.g., Prx3) + + +
NF-κB Not determined Aminoglycosides: + +
PI3-kinase + Aminoglycosides: + ?
Heat shock proteins + + +
Prevention
Nutritional supplements Inconsistent in animals
Inconclusive evidence in clinical trials
and epidemiological studies
Aminoglycosides: Consistent protection
in animals; successful clinical trials.
Cisplatin: success in animal studies
Mostly protective in animal studies
Inconclusive in clinical or field trials,
which are largely of temporary
hearing loss
+, supporting evidence exists; ?, not known or inconclusive. For drug-induced hearing loss, preference was given to results from studies in vivo or with cochlear tissues in
vitro; for age-related hearing loss, results from confounded models (See text: mice with Cdh23 mutations or catastrophic mitochondrial mutations) were de-emphasized.
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transfer functions) were compromised in 23 noise-exposed
controls but not in 11 subjects receiving NAC. Another double-
blind cross-over study assessed the efficacy of NAC in 53 male
Taiwanese steel workers that were also genotyped for deficiencies
in glutathione S-transferases, enzymes that protect against
oxidative stress (Lin et al., 2010). Noise-induced temporary
threshold shifts were small, averaging ∼3 dB at high frequencies
(3,000–6,000 Hz). NAC reduced the threshold shifts only in
a subset of workers with specific null genotypes (GSTT1 and
GSTM1) of glutathione S-transferases.
The Conundrum of Therapeutic Protection
A conclusion that can be drawn from human studies is that
antioxidants are viable therapeutic agents against drug- and
noise-induced hearing loss. To what extent dietary manipulation
can attenuate presbycusis, however, remains to be established.
But even for ototoxicity and noise trauma the situation may
not be predictable. Individual genetic predisposition and the
physiological (nutritional) state are confounding factors that are
capable of influencing the success of therapeutic interventions.
Furthermore, subtle forms of auditory damage may escape
simple audiometric tests and a final verdict on success or failure
of protective strategies may have to await more sophisticated
audiological assessments.
There is another unresolved question. While a short-term
administration of antioxidants or vitamins might be safe for
drug and noise exposure, the hazards of a life-long regimen of
nutritional supplements are unknown. Studies in animals as well
as clinical trials have warned of a potentially increased risk of
cancer and mortality associated with prolonged consumption of
antioxidants or vitamins. Specifically, meta-analyses of clinical
trials singled out beta-carotene, vitamin A, and vitamin E as
associated with increased overall mortality (Miller et al., 2005;
Bjelakovic et al., 2014). A well-balanced diet might be all that is
needed to maintain health and hearing into old age (Halliwell,
2011).
Outlook
When we compare the mechanisms of drug, noise, and age-
related hearing loss, there appear to be more similarities between
drug- and noise-induced hearing loss than between those two
and age (Table 1). One of the reasons might be that age-
related hearing loss is complexly influenced by genetics and a
lifetime of environmental factors that render its mechanisms
and manifestations highly variable. For preventive treatments,
it appears that supra-normal doses of protective agents are
successful to combat the acute damage of noise or drug trauma
but generally fail when given over the long term in an attempt to
curb the auditory deficiencies in aging.
Looking ahead, regeneration of human hair cells seems
decades away but other approaches may provide new directions.
Some aspects of ARHI may relate to the phenomenon of
cochlear synaptopathy, causing ‘‘hidden hearing loss’’ by the
loss of auditory nerve fiber/hair cell connections (Kujawa and
Liberman, 2015). In a noise-induced synaptopathy model, the
administration and the overexpression of the neurotrophins NT-
3 partially rescued the synaptopathy phenotype in mice (Wan
et al., 2014). If an appropriate diagnostic method and drug
application can be identified for ARHI, the regeneration of the
terminal nerve fibers might be a suitable therapeutic option for
at least a selected group of patients.
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